共查询到20条相似文献,搜索用时 203 毫秒
1.
患儿女,5岁,右侧腰背部红斑、丘疹、水疱伴疼痛4天,泛发全身1天。患儿11个月前确诊为再生障碍性贫血,9个月前行异基因造血干细胞移植术,术后长期口服环孢素。诊断:(1)播散性带状疱疹;(2)再生障碍性贫血异基因造血干细胞移植术后。 相似文献
2.
3.
4.
<正>玫瑰痤疮病因复杂,部分患者由于病程迁延而出现面部红色斑块或鼻赘,使治疗难度加大。我科采用5%5-氨基酮戊酸光动力疗法(ALA-PDT)治疗1例玫瑰痤疮患者,临床效果好,不良反应少,现报告如下。临床资料患者,女,43岁。主因面部红斑、丘疹、脓疱伴瘙痒3月余,于2013年3月就诊。患者3个月前无明显诱因于面部出现散在红斑、丘疹,伴轻度疼痛,偶有瘙痒,逐渐增多。曾口服多种抗组胺药、复方甘草酸苷 相似文献
5.
6.
患者,女,40岁。因面部红斑3月伴乏力于2004年2月21日入我院治疗。3个月前面部出现红斑,日晒后加重,伴局部水肿,2个月前全身乏力。同时双手掌及中跖出现红色皮疹,微痛,手足接触冷水无疼痛。 相似文献
7.
患者男,19岁,以双腋窝、腹股沟、肛周皮疹1年余,加重3个月伴疼痛来我院就诊.患者1年余前无明显诱因肛周出现散在丘疹、硬结,皮疹逐渐扩展至腹股沟及双腋窝,自觉轻度疼痛.近3个月皮疹加重,双腋窝出现散在脓肿、窦道,部分破溃,自觉明显疼痛,遂于2013年3月16日来我院就诊,诊断为聚合性痤疮,门诊予异维A酸胶囊10 mg每日2次、罗红霉素胶囊150mg每日2次口服,2个月后双腋窝、腹股沟、肛周皮疹无明显好转.既往面部、躯干有寻常痤疮病史5年,此次在我院门诊治疗后,面部及躯干的寻常痤疮皮损改善,余无特殊. 相似文献
8.
例1,女性,19岁。因四肢关节反复疼痛9个月,面部、趾指末端红斑1个月,诊断为系统性红斑狼疮(SLE),于1996年2月入院。患者于1995年4月无明显诱因出现四肢关节痛,伴不规则发热。8个月后出现面部蝶形红斑、趾指末端紫红斑。检查:神清,面部蝶形红... 相似文献
9.
10.
1临床资料患者女,48岁,因"面部秽痂3个月"就诊。患者3个月前于美容院做面膜后面部出现红斑、丘疹,伴瘙痒,自予外用药(具体不详)后面部出现褐色痂垢,皮损面积逐渐增大、增多,伴紧绷感,为避免刺激疼痛,长期未洗脸,痂垢逐渐增多。为求进一步诊治来我科就诊。患者严重焦虑,口干口有异味,大便干,舌红苔黄腻,脉弦滑。 相似文献
11.
12.
E Nagore A Pérez-Ferriols Jm Sánchez-Motilla G Serrano A Aliaga 《Journal of the European Academy of Dermatology and Venereology》2000,14(3):219-221
BACKGROUND: Triflusal is a fluorinated aspirin derivative with antiplatelet properties, which is used in Spain for the management and prevention of thromboembolic disease. CASE REPORT: A 91-year-old female developed a systemic photosensitivity reaction 15 days after beginning triflusal preventive treatment (300 mg/12 h) for prior transient ischaemic attack. Photobiological study showed an abnormal response to light in areas exposed to ultraviolet B and A radiation, with a photopatch test positive to both triflusal and its main metabolite. These observations suggested a causal relation between triflusal and the clinical findings, as described in previous reports. CONCLUSIONS: The few cases reported to date and the clinicopathological features of this case suggested an immunological response as the most likely cause of the reaction. 相似文献
13.
14.
15.
Tamagawa R Katoh N Shimazaki C Okano A Yamada S Ichihashi K Masuda K Kishimoto S 《European journal of dermatology : EJD》2005,15(4):265-267
We report on a 78-year-old Japanese woman with a 50-year history of large-plaque parapsoriasis that had evolved into cutaneous T-cell lymphoma. Her large-plaque parapsoriasis had been treated with psoralen plus ultraviolet A for 10 years. Subsequently an isolated nodule appeared on her right lower leg. Prior or concurrent patches or plaques were absent. Histology revealed a diffuse nonepidermotropic infiltrate of large lymphocytes in the dermis, which had enlarged nuclei and prominent nucleoli. A diagnosis of CD30- cutaneous large T-cell lymphoma was made. Following systemic chemotherapy, there was clinical improvement. No evidence of recurrence or systemic lymphoma has subsequently been found. 相似文献
16.
17.
18.
19.
20.
糖皮质激素联合免疫球蛋白治疗中毒性表皮坏死松解症15例疗效观察 总被引:1,自引:1,他引:1
目的:探讨糖皮质激素联合静脉注射免疫球蛋白(IVIG)治疗中毒性表皮坏死松解症(TEN)的临床疗效、不良反应和转归。方法:回顾性分析15例TEN患者采用糖皮质激素联合免疫球蛋白治疗的临床资料。结果:15例TEN患者均伴有黏膜糜烂,皮损(表皮已剥脱或即将剥脱)面积占体表面积的(19.40±6.51)%;糖皮质激素用量(以泼尼松为标准量):(1.5~2.0)mg/(kg·d);IVIG用量:(0.2~0.4)g/(kg·d),连续用药(6.0±1.3)d。联合用药第(3.0±1.3)天开始起效,痊愈9例,共治疗(23.60±5.49)d;基本痊愈5例,共治疗(16.70±3.14)d;死亡1例。所有患者均可耐受IVIG治疗。结论:糖皮质激素联合IVIG治疗TEN具有协同作用,可明显提高疗效和减少死亡,减少糖皮质激素引起的不良反应。 相似文献